Intuitive Surgical, Inc. $ISRG Stock Purchased by S.E.E.D. Planning Group LLC

Key Points

• S.E.E.D. Planning Group increased its Intuitive Surgical position by 17.1% in the third quarter, acquiring 4,901 shares for a total holding of 33,613 shares valued at approximately $13.7 million.
• Analysts maintain a “Moderate Buy” consensus on ISRG, with 22 Buy, eight Hold, and one Sell rating and an average price target of $502.53.
• Intuitive Surgical reported quarterly revenue of $2.89 billion and earnings of $2.80 per share, exceeding estimates; shares recently traded at $415.19, while insiders sold roughly $4.9 million of stock during the quarter.

S.E.E.D. Planning Group LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 17.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 33,613 shares of the medical equipment provider's stock after purchasing an additional 4,901 shares during the period. Intuitive Surgical comprises 3.2% of S.E.E.D. Planning Group LLC's holdings, making the stock its 10th biggest holding. S.E.E.D. Planning Group LLC's holdings in Intuitive Surgical were worth $13,668,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Deutsche Bank AG increased its stake in Intuitive Surgical by 9.6% in the 4th quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider's stock worth $862,108,000 after buying an additional 132,966 shares during the period. Plato Investment Management Ltd purchased a new stake in Intuitive Surgical in the 2nd quarter valued at about $4,315,000. Sycomore Asset Management bought a new position in Intuitive Surgical in the 4th quarter worth about $10,730,000. Hikari Power Ltd bought a new position in Intuitive Surgical in the 2nd quarter worth about $5,619,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Intuitive Surgical during the second quarter worth approximately $14,316,000. Institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Wells Fargo & Company reiterated an "overweight" rating and issued a $487.00 price target (down from $654.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Weiss Ratings reissued a "hold (c)" rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Sanford C. Bernstein restated an "outperform" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Bank of America lowered their price objective on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Finally, HSBC cut shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 target price on the stock. in a report on Thursday, July 30th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $502.53.

Intuitive Surgical Stock Up 2.6%

Shares of NASDAQ ISRG traded up $10.43 during mid-day trading on Wednesday, reaching $415.19. 795,867 shares of the company were exchanged, compared to its average volume of 2,416,921. The stock has a market cap of $146.68 billion, a price-to-earnings ratio of 47.57, a P/E/G ratio of 3.07 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The firm has a 50-day moving average of $382.47 and a 200 day moving average of $412.07.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the previous year, the firm earned $1.81 earnings per share. The firm's quarterly revenue was up 18.4% compared to the same quarter last year. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insider Activity

In other news, EVP Mark Brosius sold 77 shares of the company's stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the transaction, the executive vice president owned 881 shares in the company, valued at $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the executive vice president directly owned 5,320 shares of the company's stock, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,370 shares of company stock worth $4,891,989 over the last quarter. Company insiders own 0.60% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company's products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.